Basic Fund Data
Fund Provider:	XShares Group
Asset Class:	Closed Funds
Fund Category:	Closed Funds
Ticker:	HRJ
Expense Ratio:	0.72%
Fund Category Expense Ratio Average:	0.52%
Options:	No
Fund Inception Date:	04-03-2007
Fund Structure:	Open-Ended
Fund Weighting Restrictions:	Non-diversified Fund Rules
Fund Tracking Method:	Full Replication
Dividend Payment Frequency:
Basic Index Data
Index Name:	HealthShares European Drugs Index
Index Provider:	HealthShares
No of Index Holdings:	Under 100
Explanation of Index Strategy
Security Selection Category:	Screened
Security Selection Method:	Thematic
Security Selection Frequency:	Quarterly
Index Weighting Category:	Fixed Weight
Index Weighting Method:	Equal then Float
Index Weighting Frequency:	Each Stock as Needed

No Data Found

No Data Found

No Data Found

Index Snapshot:

THIS ETF HAS BEEN LIQUIDATED AS OF DECEMBER 2008. The HealthShares European Drugs ETF (Ticker: HRJ) seeks to replicate as closely as possible, before expenses, the total return performance of the HealthShares European Drugs Index. The index is comprised of companies headquartered in Europe and quoted on at least one European Stock Exchange that are engaged in the research, clinical development, manufacturing and commercialization of pharmaceutical products. Companies must have a minimum market capitalization greater than $100 million and less than $15 billion for at least two of the three proceeding quarters. Stocks are equally weighted when the fund is formed and then float with the market thereafter. When the weight of an individual stock reaches 15% of the index value it is adjusted down to 10%, and when a stocks falls to 2.5% it is adjusted up to 5%. S&P is the administrator of HealthShares indexes.